Grand River Aseptic Manufacturing Expands Syringe-Filling CapabilitiesBy
Grand River Aseptic Manufacturing (GRAM), a Grand Rapids, Michigan-based provider of sterile-manufacturing services, is expanding its capabilities in syringe filling at its manufacturing facility in Grand Rapids.
GRAM is installing a Colanar FSV syringe filler, which will use GRAM’s existing single-use systems and support both small- molecule active pharmaceutical ingredients and biologics projects. The purchase of the syringe filler follows a partnership deal reached in November 2017 between GRAM and Arlington Capital Partners, a private equity firm based in Washington, D.C., under which GRAM announced Arlington as its new majority owner. The partnership is expected to provide funding for GRAM to expand and add capacity to its parenteral development and manufacturing services.
The syringe filler is expected to be qualified and operational by the second quarter of 2018. In addition to filling syringes, the new filler is capable of handling cartridges, according to GRAM.